Clinical Trials at Medif
During the past decade, Medif conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on
average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Medif"
#1 collaborator was "Atea Pharmaceuticals, Inc." with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Medif
According to Clinical.Site data, the most researched conditions in "Medif" are
"COVID-19" (2 trials), "Coronary Heart Disease (CHD)" (1 trials), "Dyslipidemia" (1 trials), "Gastroesophageal Reflux" (1 trials) and "Long COVID" (1 trials). Many other conditions were trialed in "Medif" in a lesser frequency.
Clinical Trials Intervention Types at Medif
Most popular intervention types in "Medif" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Evolocumab" (2 trials), "Placebo" (2 trials), "Esomeprazole" (1 trials), "Esomeprazole Placebo" (1 trials) and "RO7496998" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Medif
The vast majority of trials in "Medif" are
5 trials for "All" genders.
Clinical Trials Status at Medif
Currently, there are NaN active trials in "Medif".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Medif,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Medif, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".